Expression of CB2 cannabinoid receptor mRNA in adult rat retina

Visual Neuroscience

Volumn 17, Issue 1, 2000, Pages 91-95

  Lu, Qingjun ^a   Straiker, Alex ^a   Lu, Qingxian ^b   Maguire, Greg ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Cannabinoid receptors; Ganglion cells; In situ hybridization; Retina; RT PCR

Indexed keywords

CANNABINOID RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; IN SITU HYBRIDIZATION; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RAT; RETINA; RETINA GANGLION CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CANNABINOIDS; DNA PRIMERS; IN SITU HYBRIDIZATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RETINA; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034023857     PISSN: 09525238     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0952523800171093     Document Type: Article

References (28)

1. AKAM, M.E. (1983). The location of ultrabithorax transcripts in drosophila tissue sections. EMBO Journal 2, 2075-2084.
2. ANGERER, L.M. & ANGERER, R.C. (1981). Detection of poly A RNA in sea urchin eggs and embryos by quantitative in situ hybridization. Nucleic Acids Research 9, 2819-2840.
3. BUCKLEY, N.E., HANSSON, S., HARTA, G. & MEZEY, É. (1998). Expression of CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82, 1131-1149.
4. CALIGNANO, A., LA RANA, G., GIUFFRIDA, A. & PIOMELLI, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature 394, 277-281.
5. CHOI, D.W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
6. DEADWYLER, S.A., HAMPSON, R.E., MU, J., WHYTE, A. & CHILDERS, S. (1995). Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. The Journal of Pharmacology and Experimental Therapeutics 273, 734-743.
7. DERKINDEREN, P., TOUTANT, M., BURGAYA, F., LE BERT, M., SICILIANO, J.C., DE FRANISIS, V., GELMAN, M. & GIRAULT, J.A. (1996). Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 273, 1919-1922.
8. DREYER, E.B., ZURAKOWSKI, D., SCHUMER, R.A., PODOS, S.M. & LIPTON, S.A. (1996). Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Archives of Ophthalmology 114, 299-305.
9. FACCI, L., DAL TOSO, R., ROMANELLO, S., BURIANI, A., SKAPER, S.D. & LEON, A. (1995). Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proceedings of the National Academy of Sciences of the U.S.A. 92, 3376-3380.
10. FRIED, P.A. (1995). The Ottawa prenatal prospective study (OPPS): Methodological issues and findings - it's easy to throw the baby out with the bath water. Life Science 56, 2159-2168.
11. GALIEGUE, S., MARY, S., MARCHAND, J., DUSSOSSOY, D., CARRIERE, D., CARAYON, P., BOUABOULA, M., SHIRE, D., LE FUR, G. & CASELLAS, P. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry 232, 54-61.
12. GRIFFIN, G., FERNANDO, S.R., ROSS, R.A., MCKAY, N.G., ASHFORD, M.L., SHIRE, D., HUFFMAN, J.W., YU, S., LAINTON, J.A. & PERTWEE, R.G. (1997). Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. European Journal Pharmacology 339, 53-61.
13. HAMPSON, A.J., BORNHEIM, L.M., SCANZIANI, M., YOST, C.S., GRAY, A.T., HANSEN, B.M., LEONOUDAKIS, D.J. & BICKLER, P.E. (1998). Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. Journal Neurochemistry 70, 671-676.
14. HEPLER, R.S. & FRANK, I.R. (1971). Marijuana smoking and intraocular pressure. JAMA 217, 1392.
15. MACKIE, K., LAI, Y., WESTENBROEK, R. & MITCHELL, R. (1995). Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Journal Neuroscience 15, 6552-6561.
16. MARTIN, W.J., HOHAMANN, A.G. & WAEKER, J.M. (1996). Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects. Journal Neuroscience 16, 6601-6611.
17. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
18. MELDRUM, B. & GARTHWAITE, J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends in Pharmacological Sciences 11, 379-387.
19. MUNRO, S., THOMAS, K. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
20. PERTWEE, R.G. (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacology and Therapeutics 74, 129-180.
21. + channels. Neurophamacology 35, 983-991.
22. SCHLICKER, E., TIMM, J. & GOTHERT, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedebergs Archives of Pharmacologv 354, 791-795.
23. SKAPER, S.D., BURIANI, A., DAL TOSO, R., PETRELLI, L., ROMANELLO, S., FACCI, L. & LEON, A. (1996). The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic deatb in cerebellar granule neurons. Proceedings of the National Academy of Sciences of the U.S.A. 93, 3984-3989.
24. STELLA, N., SCHWEITZER, P. & PIOMELLI, D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
25. STRAIKER, A., STELLA, N., PIOMELLI, D., MACKIE, K., KARTEN, H.J. & MAGUIRE, G. (1998). Immunological localization of cannabinoid CB1 receptors in vertebrate retina. 28th Annual Meeting of Society for Neuroscience Abstract 24, 2092 (Item 833.12).
26. TWITCHELL, W., BROWN, S. & MACKIE, K. (1997). Cannabinoids inhibit N and P/Q-type calcium currents in cultured rat hippocampal neurons. Journal Neurophysiology 78, 43-50.
27. VORWERK, C.K., LlPTON, S.A., ZURAKOWSKI, D., HYMAN, B.T., SABEL, B.A. & DREYER, E.B. (1996). Chronic low dose glutamate is toxic to retina ganglion cells, Investigative Ophthalmology and Visual Science 37, 1618-1624.
28. ZELTSER, R., SELTZER, Z., EISEN, A., FEIGENBAUM, J.J. & MECHOULAM, R. (1991). Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties. Pain 47, 95-103.